// startup autopsy
Gamma Medica-Ideas
Molecular imaging innovation that couldn't break into the clinic
marketfitSlow Death
Years-long decline before final shutdown · Fatal mistake: The company underestimated the length and cost of the reimbursement approval process, leaving it without a sustainable revenue path before funding was exhausted.
| Founded | 2000 |
|---|---|
| Closed | 2013 |
| Country | USA |
| Sector | Healthtech |
50%
50%
Key Events Timeline
FOUNDING
Gamma Medica-Ideas founded to commercialize molecular breast imaging technology.
PRODUCT LAUNCH
Company launches its LumaGEM molecular breast imaging system targeting clinical radiology departments.
FUNDING
Secures final known funding round of $14M to advance commercialization efforts.
REGULATORY ACTION
Reimbursement classification delays by CMS limit hospital willingness to invest in MBI devices.
SHUTDOWN
Gamma Medica-Ideas ceases operations after failing to achieve commercial scale or secure additional investment.